Variable | Total (n = 50) | miR-1290 expression | p value | |
---|---|---|---|---|
Low (n = 23) | High (n = 27) | |||
Age (year) | 64.00 ± 1.62 | 63.26 ± 2.46 | 64.63 ± 2.19 | 0.679 |
Sex | Â | Â | Â | 0.057 |
 Male | 33 | 12 | 21 |  |
 Female | 17 | 11 | 6 |  |
BMI (kg/m2) | 23.83 (21.33–25.54) | 24.24 (20.96–27.64) | 23.36 (21.45–25.24) | 0.483 |
Smoke | Â | Â | Â | 0.741 |
 Yes | 23 | 10 | 13 |  |
 No | 27 | 13 | 14 |  |
Alcohol | Â | Â | Â | 0.990 |
 Yes | 13 | 6 | 7 |  |
 No | 37 | 17 | 20 |  |
Hypertension | Â | Â | Â | 0.309 |
 Yes | 19 | 7 | 12 |  |
 No | 31 | 16 | 15 |  |
Diabetes | Â | Â | Â | 0.777 |
 Yes | 5 | 2 | 3 |  |
 No | 45 | 21 | 24 |  |
Location | Â | Â | Â | 0.555 |
 colon | 24 | 10 | 14 |  |
 rectum | 26 | 13 | 13 |  |
Tumor size (cm) | 3.50 (3.00–3.05) | 3.00 (2.30–4.00) | 4.00 (3.00–5.00) | 0.037* |
Lymphatic invasion | Â | Â | Â | 0.019* |
 Positive | 22 | 6 | 16 |  |
 Negative | 28 | 17 | 11 |  |
Venous invasion | Â | Â | Â | 0.019* |
 Positive | 22 | 6 | 16 |  |
 Negative | 28 | 17 | 11 |  |
Distant metastasis | Â | Â | Â | 0.041* |
 Positive | 16 | 4 | 12 |  |
 Negative | 34 | 19 | 15 |  |
Differentiation | Â | Â | Â | 0.025* |
 Well | 1 | 1 | 0 |  |
 Moderate | 39 | 21 | 18 |  |
 Poor | 10 | 1 | 9 |  |
TNM stage (AJCC) | Â | Â | Â | 0.047* |
 I and II | 25 | 15 | 10 |  |
 III and IV | 25 | 8 | 17 |  |
CRP (mg/l) | Â | Â | Â | 0.918 |
 < 10 | 41 | 19 | 22 |  |
 ≥ 10 | 9 | 4 | 5 |  |
CEA (ng/ml) | Â | Â | Â | 0.022* |
 < 5 | 33 | 19 | 14 |  |
 ≥ 5 | 17 | 4 | 13 |  |
CA199 (U/ml) | Â | Â | Â | 0.400 |
 < 37 | 41 | 20 | 21 |  |
 ≥ 37 | 9 | 3 | 6 |  |
CA125 (U/ml) | Â | Â | Â | 0.351 |
 < 35 | 49 | 23 | 26 |  |
 ≥ 35 | 1 | 0 | 1 |  |
CA242 (U/ml) | Â | Â | Â | 0.183 |
 < 20 | 48 | 23 | 25 |  |
 ≥ 20 | 2 | 0 | 2 |  |
CA211 (ng/ml) | Â | Â | Â | 0.650 |
 < 5 | 47 | 22 | 25 |  |
 ≥ 5 | 3 | 1 | 2 |  |